Cargando…
Cardiometabolic Risk in First Episode Psychosis Patients
Previous research in patients with schizophrenia in European and USA population groups has demonstrated a high prevalence of metabolic syndrome and disease progression (~35%–40%) and increased risk for cardiovascular disease and long-term mortality. Limited research has determined the prevalence of...
Autores principales: | Smith, Jo, Griffiths, Lisa A., Band, Marie, Horne, Dominic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732528/ https://www.ncbi.nlm.nih.gov/pubmed/33329382 http://dx.doi.org/10.3389/fendo.2020.564240 |
Ejemplares similares
-
Early Intervention in Psychosis: Effectiveness and Implementation of a Combined Exercise and Health Behavior Intervention Within Routine Care
por: Smith, Jo, et al.
Publicado: (2020) -
The effect of early life events on glucose levels in first-episode psychosis
por: Garcia-Rizo, Clemente, et al.
Publicado: (2022) -
Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
por: Gaughran, Fiona, et al.
Publicado: (2019) -
Quality of life in patients with the first-episode psychosis
por: Usova, A., et al.
Publicado: (2021) -
Association between serum carcinoembryonic antigen and cardiometabolic risks: Implication for cardiometabolic prevention
por: Chang, Chia-Hao, et al.
Publicado: (2023)